Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) discovers, develops, licenses, manufactures, and markets ...

Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...

The FDA accepted Bristol Myers' sBLA for Opdivo plus Yervoy as ... 2024 for the same indication by the China National Medical Products Administration. Last week, Bristol Myers announced the ...

In the third quarter of 2024, BMY reported earnings that exceeded expectations, although analysts noted that the beat was driven largely by legacy products and inventory dynamics. The company ...

Bristol-Myers Squibb Company (NYSE:BMY) 45th Annual TD Cowen Health Care Conference March 4, 2025 2:30 PM ETCompany ParticipantsAdam Lenkowsky - ...

In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against other Friday’s worst performing stocks. Wall Street’s main indices bounced back on ...

Successful products can generate significant revenue ... unchanged since the latest earnings results. Founded in 1887, Bristol-Myers Squibb (NYSE:BMY) is a global biopharmaceutical company that ...